Sartorius Stedim Biotech S.A. (EPA:DIM)

Market Cap	19.84B
Revenue (ttm)	2.86B
Net Income (ttm)	204.30M
Shares Out	97.30M
EPS (ttm)	2.11
PE Ratio	96.60
Forward PE	43.62
Dividend	0.69 (0.34%)
Ex-Dividend Date	Apr 2, 2025

Volume	9,430
Average Volume	60,549
Open	203.40
Previous Close	203.90
Day's Range	200.00 - 203.80
52-Week Range	143.20 - 239.80
Beta	0.93
RSI	56.05
Earnings Date	Jul 22, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 9,901
• Stock Exchange: Euronext Paris
• Ticker Symbol: DIM

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.